Supportare l’uso dell’NT-proBNP per meglio identificare l’insufficienza cardiaca nei pazienti con diabete di tipo 2

20 Giugno 2023

Supportare l’uso dell’NT-proBNP per meglio identificare l’insufficienza cardiaca nei pazienti con diabete di tipo 2

Heart failure (HF) is a chronic disease that causes approximately 300,000 and 250,000 deaths per year in Europe and United States, respectively. Type 2 Diabetes Mellitus (T2DM) is one the major risk factors of HF, and the investigation of NT-proBNP might support the early identification of HF in T2DM sufferers. Nevertheless, this parameter is poorly investigated. Thus, we aimed to demographically and clinically characterize diabetic patients which were prescribed with NT-proBNP in the primary care setting.

  • Autori: Lapi F, Marconi E, Medea G, Parretti D, Piccinni C, Maggioni AP, Cricelli C.
  • Titolo: To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes.
  • Rivista: Endocrine. 2023 Oct;82(1):42-46. doi: 10.1007/s12020-023-03419-2.
  • Link pubblicazione